Clomipramine Treatment of Obsessive-Compulsive Disorder: II. Biochemical Aspects

Archives of General Psychiatry

Volumn 37, Issue 11, 1980, Pages 1289-1294

  Thorän, Peter ^a   Åsberg, Marie ^a   Bertilsson, Leif ^a   Mellstrüm, Britt ^a   Sjüqvist, Folke ^a   Träskman, Lil ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CLOMIPRAMINE; NORTRIPTYLINE; PLACEBO;

CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; COMPULSION; DRUG THERAPY; OBSESSION; ORAL DRUG ADMINISTRATION; THERAPY;

ADULT; CLOMIPRAMINE; FEMALE; GLYCOLS; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PHENYLACETATES;

EID: 0019160802     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1980.01780240087010     Document Type: Article

References (22)

1. Carlsson A, Corrodi H, Fuxe K, et al: Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-metatyramine. Eur J Pharmacol 5:357-366, 1969.
2. Hamberger B, Tuck JR: Effect of tricyclic antidepressants on the uptake of noradrenaline and 5-hydroxytryptamine in rat brain slices incubated in buffer or human plasma. Eur J Clin Pharmacol 5:229-235, 1973.
3. Bertilsson L, Åsberg M, Thorän P: Differential effect of chlorimipramine and nortriptyline on cerebrospinal fluid amine metabolites of serotonin and noradrenaline in depression. Eur J Clin Pharmacol 7:365-368, 1974.
4. Åsberg M, Ringberger V-A, Sjüqvist F, et al: Monoamine metabolites in cerebrospinal fluid and serotonin-uptake inhibition during treatment with chlorimipramine. Clin Pharmacol Ther 21:201-207, 1977.
5. Träskman L, Åsberg M, Bertilsson L, et al: Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression. Clin Pharmacol Ther 26:600-610, 1979.
6. Ananth J: Treatment of obsessive-compulsive neurosis with clomipramine (Anafranil). J Int Med Res 5(suppl):38-41, 1977.
7. Mellstrüm B, Tybring G: Ion-pair liquid chromatography of steadystate plasma levels of chlorimipramine and demethylchlorimipramine. J Chromatogr 143:597-601, 1977.
8. Mellstrüm B, Braithwaite R: Ion-pair liquid chromatography of amitriptyline and metabolites in plasma. J Chromatogr 157:379-385, 1978.
9. Bertilsson L, Atkinson AJ Jr, Althaus JR, et al: Quantitative determination of 5-hydroxyindole-3-acetic acid in cerebrospinal fluid by gas chromatography-mass spectrometry. Anal Chem 44:1434-1438, 1972.
10. Bertilsson L, Palmär L: Determination of isomeric acid dopamine metabolites by mass fragmentography. Life Sci 13:859-866, 1973.
11. Bertilsson L: Quantitative determination of 4-hydroxy-3-methoxyphenyl glycol and its conjugates in cerebrospinal fluid by mass fragmentography. J Chromatogr 87:147-153, 1973.
12. Wode-Helgodt B, Sedvall G: Correlation between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women. Commun Psychopharmacol 2:177-183, 1978.
13. Åsberg M, Bertilsson L, Thorän P, et al: CSF metabolites in depressive illness, in Symposia Medica Hoechst. Stuttgart, Germany, Friedrich-Karl Schattauer Verlag, 1978, vol 13, pp 293-305.
14. Gottfries CG, Gottfries I, Johansson B, et al: Acid monoamine metabolites in human cerebrospinal fluid and their relation to age and sex. Neuropharmacology 10:665-672, 1971.
15. Chadwick D, Jenner P, Reynolds EH: Amines, anticonvulsants, and epilepsy. Lancet 1:473-476, 1975.
16. Åsberg M, Bertilsson L, Tuck D, et al: Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline. Clin Pharmacol Ther 14:277-286, 1973.
17. Muscettola G, Goodwin FK, Potter WZ, et al: Imipramine and desipramine in plasma and spinal fluid: Relationship to clinical response and serotonin metabolism. Arch Gen Psychiatry 35:621-625, 1978.
18. Van Praag HM: New evidence of serotonin-deficient depressions, in Symposia Medica Hoechst. Stuttgart, Germany, Friedrich-Karl Schattauer Verlag, 1978, vol 13, pp 9-16.
19. Åsberg M, Thorän P, Träskman L, et al: ‘Serotonin depression’: A biochemical subgroup within the affective disorders? Science 191:478-480, 1976.
20. Van Praag HM, Korf J: Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification? Psychopharmacologia 19:148-152, 1971.
21. Fuxe K, Ügren SO, Agnati L, et al: On the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline: Evidence for 5hydroxytryptamine receptor blocking. Neurosci Letters 6:339-343, 1977.
22. Siwers B, Ringberger V-A, Tuck JR, et al: Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients. Clin Pharmacol Ther 21:194-200, 1977.